FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Kit, Rna Detection, Human Papillomavirus
PMA: P120007
·
Supplement: S030
·
Decision Jun 2, 2023
Classifications
1
FEI Numbers
1
Registration Numbers
1
Basic Information
- Device Name
- Kit, Rna Detection, Human Papillomavirus
- Trade Name
- Aptima HPV 16 18/45 Genotype Assay
- PMA Number
- P120007
- Supplement Number
- S030
- Device Class
- FDA Class 3
- Product Code
- OYB
- Generic Name
- Kit, rna detection, human papillomavirus
- Medical Specialty
- Unknown
- Advisory Committee
- Microbiology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- June 2, 2023
- Date Received
- March 28, 2022
- Supplement Type
- Normal 180 Day Track
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
Approval for the addition of manual post-cytology (cytology by ThinPrep Genesis Processor) aliquot, pre-cytology aliquot and post-cytology (cytology by ThinPrep Genesis Processor) aliquot removed by the ThinPrep Genesis Processor as acceptable samples for the Aptima HPV Assay and Aptima HPV 16 18/45 Genotype Assay.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OYB | Kit, Rna Detection, Human Papillomavirus | FDA class 3 | Unknown |